This report analyses various environmental risk assessment practices that are currently in place for food-related substances in both the EU and the USA. Within the EU, REACH requires the systematic review of the toxicity of chemicals, with varying degrees of extensiveness of testing required based on the quantities of the chemicals used in practice. Genetically modified organisms are another example of how the environmental impacts of food-producing crops are assessed. The requirements for the use of substances in organic agriculture imply that these should also be assessed for environmental impact. In the USA, the FDA requires environmental assessments for food substance requiring this agency's action. The EPA has elaborated guidelines for ecological risk assessment that show parallels with the food safety assessment, including the stages of problem formulation, analysis (assessment), and risk characterisation. Also the stakeholder involvement and risk management play an important role in the procedures envisaged by these guidelines. The utility of integrated assessments has been further stressed by WHO/IPCS. It is considered that the new integrated risk-analysis approach recommended by SAFE FOODS can benefit from the integration of environmental issues, including their assessment in the risk-benefit stage of the risk analysis cycle.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.